Revvity Inc. (RVTY) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Revvity Inc. (RVTY) has a cash flow conversion efficiency ratio of 0.016x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($115.23 Million) by net assets ($7.18 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See RVTY cash and liquid assets coverage to measure how many days the company can operate on defensive assets alone.
Revvity Inc. - Cash Flow Conversion Efficiency Trend (1989–2025)
This chart illustrates how Revvity Inc.'s cash flow conversion efficiency has evolved over time, based on yearly financial data.
Revvity Inc. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Revvity Inc. ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Dr. Reddy’s Laboratories Ltd ADR
NYSE:RDY
|
0.029x |
|
Nordex SE
F:NDX1
|
0.492x |
|
JAMES HARDIE INDUST.ADR/1
F:JHA0
|
N/A |
|
Eurofins Scientific SE
F:ESF0
|
0.073x |
|
Zebra Technologies Corporation
NASDAQ:ZBRA
|
0.051x |
|
TELECOM ITALIA ADR 1
F:TQIA
|
0.082x |
|
Pinnacle West Capital Corp
NYSE:PNW
|
0.092x |
|
Chocoladefabriken Lindt & Spruengli AG Part
SW:LISP
|
-0.032x |
Annual Cash Flow Conversion Efficiency for Revvity Inc. (1989–2025)
The table below shows the annual cash flow conversion efficiency of Revvity Inc. from 1989 to 2025. For the full company profile with market capitalisation and key ratios, see market value of Revvity Inc..
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $7.25 Billion | $581.78 Million | 0.080x | -2.09% |
| 2024-12-31 | $7.67 Billion | $628.30 Million | 0.082x | +606.86% |
| 2023-12-31 | $7.87 Billion | $91.27 Million | 0.012x | -87.41% |
| 2022-12-31 | $7.38 Billion | $679.81 Million | 0.092x | -53.39% |
| 2021-12-31 | $7.14 Billion | $1.41 Billion | 0.198x | -17.29% |
| 2020-12-31 | $3.74 Billion | $892.18 Million | 0.239x | +84.90% |
| 2019-12-31 | $2.81 Billion | $363.47 Million | 0.129x | +7.35% |
| 2018-12-31 | $2.58 Billion | $311.04 Million | 0.120x | +4.42% |
| 2017-12-31 | $2.50 Billion | $288.45 Million | 0.115x | -29.22% |
| 2016-12-31 | $2.15 Billion | $350.62 Million | 0.163x | +19.68% |
| 2015-12-31 | $2.11 Billion | $287.10 Million | 0.136x | -1.35% |
| 2014-12-31 | $2.04 Billion | $281.60 Million | 0.138x | +73.42% |
| 2013-12-31 | $1.99 Billion | $158.59 Million | 0.080x | +1.36% |
| 2012-12-31 | $1.94 Billion | $152.17 Million | 0.078x | -35.74% |
| 2011-12-31 | $1.84 Billion | $224.87 Million | 0.122x | +43.09% |
| 2010-12-31 | $1.93 Billion | $164.25 Million | 0.085x | -6.56% |
| 2009-12-31 | $1.63 Billion | $148.72 Million | 0.091x | -34.29% |
| 2008-12-31 | $1.57 Billion | $217.84 Million | 0.139x | +6.70% |
| 2007-12-31 | $1.58 Billion | $205.13 Million | 0.130x | +61.21% |
| 2006-12-31 | $1.58 Billion | $127.44 Million | 0.081x | -35.93% |
| 2005-12-31 | $1.65 Billion | $208.09 Million | 0.126x | -8.30% |
| 2004-12-31 | $1.46 Billion | $200.76 Million | 0.137x | +10.76% |
| 2003-12-31 | $1.35 Billion | $167.47 Million | 0.124x | +53.17% |
| 2002-12-31 | $1.25 Billion | $101.50 Million | 0.081x | -10.37% |
| 2001-12-31 | $1.36 Billion | $123.30 Million | 0.090x | -54.75% |
| 2000-12-31 | $728.39 Million | $145.55 Million | 0.200x | -4.96% |
| 1999-12-31 | $550.80 Million | $115.80 Million | 0.210x | +20.74% |
| 1998-12-31 | $399.70 Million | $69.60 Million | 0.174x | +64.27% |
| 1997-12-31 | $328.30 Million | $34.80 Million | 0.106x | -51.74% |
| 1996-12-31 | $365.10 Million | $80.20 Million | 0.220x | -46.34% |
| 1995-12-31 | $366.90 Million | $150.20 Million | 0.409x | +90.13% |
| 1994-12-31 | $445.40 Million | $95.90 Million | 0.215x | -8.29% |
| 1993-12-31 | $477.50 Million | $112.10 Million | 0.235x | -13.00% |
| 1992-12-31 | $473.60 Million | $127.80 Million | 0.270x | +8.74% |
| 1991-12-31 | $420.70 Million | $104.40 Million | 0.248x | -29.01% |
| 1990-12-31 | $369.60 Million | $129.20 Million | 0.350x | +132.82% |
| 1989-12-31 | $349.00 Million | $52.40 Million | 0.150x | -- |
About Revvity Inc.
Revvity, Inc. provides health sciences solutions, technologies, and services. The company offers instruments, reagents, software, subscriptions, detection and imaging technologies, extended warranties, training and services; and instruments, reagents, assay platforms and software products for early detection of common and rare conditions, such as pregnancy and early childhood, as well as infectio… Read more